Cell line · CVCL_9720
Papers36
1 to 20 of 36
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Pancreatic Cancer-Derived Small Extracellular Vesicles Remodel Hepatic Pre-Metastatic Niche via Hybrid Epithelial-Mesenchymal States. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Hidden Metabolites in Glutinous Rice Huangjiu and Their Antioxidant Potential. | Foods | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Differential regulation of ZFAS1 splice variants by endoplasmic reticulum stress in hepatocyte cell lines. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Frizzled 7 drives amplification of cancer stem-cell subpopulations and the aggressiveness and poor differentiation of human hepatocellular carcinoma. | PLoS One | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Hepatitis B virus core/capsid protein induces hepatocellular carcinoma progression via long non-coding RNA KCNQ1OT1/miR-335-5p/CDC7 axis. | Transl Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease. | eGastroenterology | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Proteolytic shedding of CD46 from human hepatocytes indicates liver stress. | Heliyon | 2024 | Its Methods give the RRID and name the line | PubMed | |
| An hepatitis B and D virus infection model using human pluripotent stem cell-derived hepatocytes. | EMBO Rep | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Soluble CD46 as a diagnostic marker of hepatic steatosis. | EBioMedicine | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma. | Clin Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| IL-33/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen-mediated toxicological immunity. | Cell Commun Signal | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Concentration of Na+-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma cells for hepatitis B virus. | Sci Rep | 2021 | Its Methods give the RRID and name the line | PubMed | |
| TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer. | J Exp Med | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells. | Sci Rep | 2021 | Cellosaurus cites it | PubMed | |
| Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response. | Gastroenterology | 2019 | Cellosaurus cites it | PubMed | |
| In-Depth Proteome Analysis Highlights HepaRG Cells as a Versatile Cell System Surrogate for Primary Human Hepatocytes. | Cells | 2019 | Cellosaurus cites it | PubMed | |
| A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis. | J Toxicol Sci | 2017 | Cellosaurus cites it | PubMed | |
| Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes. | Methods Mol Biol | 2017 | Cellosaurus cites it | PubMed | |
| Stable Overexpression of the Constitutive Androstane Receptor Reduces the Requirement for Culture with Dimethyl Sulfoxide for High Drug Metabolism in HepaRG Cells. | Drug Metab Dispos | 2017 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_9720/papers